Pancreatic adenocarcinomas without KRAS, TP53, CDKN2A and SMAD4 mutations and CDKN2A/CDKN2B copy number alterations: a review of the genomic landscape to unveil therapeutic avenues
@article{CCO109751,
author = {Ioannis A. Voutsadakis and Antonia Digklia},
title = {Pancreatic adenocarcinomas without KRAS, TP53, CDKN2A and SMAD4 mutations and CDKN2A/CDKN2B copy number alterations: a review of the genomic landscape to unveil therapeutic avenues},
journal = {Chinese Clinical Oncology},
volume = {12},
number = {1},
year = {2023},
keywords = {},
abstract = {},
issn = {2304-3873}, url = {https://cco.amegroups.org/article/view/109751}
}